DocGo Inc. (NASDAQ:DCGO) Given Average Recommendation of "Moderate Buy" by Analysts

Shares of DocGo Inc. (NASDAQ:DCGO - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the six ratings firms that are covering the company, Marketbeat reports. Three equities research analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average twelve-month price target among analysts that have issued ratings on the stock in the last year is $3.56.

Several brokerages recently commented on DCGO. Needham & Company LLC dropped their price target on shares of DocGo from $4.00 to $3.00 and set a "buy" rating for the company in a research report on Friday, May 9th. Canaccord Genuity Group reissued a "hold" rating and set a $1.45 price objective (down from $5.00) on shares of DocGo in a research note on Monday, May 12th. Deutsche Bank Aktiengesellschaft downgraded DocGo from a "buy" rating to a "hold" rating and dropped their price objective for the stock from $5.00 to $2.85 in a report on Friday, February 28th. Stifel Nicolaus reduced their target price on DocGo from $6.50 to $5.50 and set a "buy" rating on the stock in a report on Friday, February 28th. Finally, BTIG Research downgraded DocGo from a "buy" rating to a "neutral" rating in a research report on Friday, May 9th.

DocGo Stock Up 7.0%

Shares of NASDAQ:DCGO opened at $1.53 on Friday. The company has a market cap of $156.03 million, a P/E ratio of 5.46, a P/E/G ratio of 14.16 and a beta of 0.94. The business has a fifty day simple moving average of $1.95 and a 200-day simple moving average of $3.36. DocGo has a 52 week low of $1.23 and a 52 week high of $5.68.

DocGo (NASDAQ:DCGO - Get Free Report) last posted its quarterly earnings results on Thursday, May 8th. The company reported ($0.09) EPS for the quarter, missing the consensus estimate of ($0.01) by ($0.08). The business had revenue of $96.03 million during the quarter, compared to analysts' expectations of $104.25 million. DocGo had a net margin of 4.35% and a return on equity of 8.90%. Sell-side analysts expect that DocGo will post 0.25 earnings per share for the current fiscal year.

Institutional Investors Weigh In On DocGo

Several large investors have recently made changes to their positions in DCGO. Summit Investment Advisors Inc. boosted its position in DocGo by 38.7% during the 4th quarter. Summit Investment Advisors Inc. now owns 10,639 shares of the company's stock worth $45,000 after purchasing an additional 2,968 shares during the period. Summit Securities Group LLC acquired a new position in shares of DocGo during the first quarter worth about $34,000. Prudential Financial Inc. purchased a new stake in shares of DocGo in the fourth quarter worth about $55,000. Royce & Associates LP acquired a new stake in shares of DocGo in the fourth quarter valued at about $64,000. Finally, Boothbay Fund Management LLC grew its stake in shares of DocGo by 154.9% in the fourth quarter. Boothbay Fund Management LLC now owns 27,445 shares of the company's stock valued at $116,000 after buying an additional 77,445 shares in the last quarter. Institutional investors and hedge funds own 56.44% of the company's stock.

DocGo Company Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.